|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.53 USD | -1.01% |
|
-3.28% | -82.29% |
| 11/12 | Sector Update: Health Care Stocks Mixed Premarket Thursday | MT |
| 11/12 | Sarepta Therapeutics Refinances $291 Million in Convertible Senior Notes Due 2027 | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 190.2Cr | 12.37% | 11.47% | 19.71% | 6.51% | -0.85x | |
| 56Cr | -101.6% | -95.67% | -214.5% | -38.02% | 1.49x | |
| Average | 123.11Cr | -44.61% | -42.1% | -97.39% | -15.75% | 0.32x | |
| Weighted average by Cap. | 108.71Cr | -56.84% | -53.6% | -122.53% | -20.53% | 0.57x |
- Stock Market
- Equities
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition